-
Science Saturday: Regenerative medicine in novel fetal therapy program
Share this:
Specialists at Mayo Clinic are pioneering a life-saving procedure as part of a clinical trial for babies with congenital diaphragmatic hernia (CDH).
When a baby’s lungs are not adequately developed at birth, severe complications and even death can result. Waiting for the baby to be born to intervene may be too late. A new study is underway to document fetal lung growth from early intervention before birth.
CDH develops when a baby’s chest cavity is compressed and lung development is restricted because the diaphragm does not close completely and the abdominal organs push into the chest cavity. CDH is a life-threatening condition affecting 1 in 2,500 births. Read the rest of the article on the Center for Regenerative Medicine blog.
___________________________________________
Other Mayo Clinic medical research websites:
- Research at Mayo Clinic
- Discovery’s Edge
- Advancing the Science
- Forefront
- Mayo Clinic Center for Individualized Medicine
- Mayo Clinic Center for Innovation
- Center for Regenerative Medicine
- Center for the Science of Health Care Delivery
Share this:
Related articles
DEAR MAYO CLINIC: My 4-year-old daughter already has had three ear infections this winter. When she isn't feeling well, our entire family is miserable. The pediatrician ...
Healthy Weight Week will be observed Jan. 15–21, so this is a good time for a reminder of the connection between weight and health during ...
DEAR MAYO CLINIC: We’ve noticed an indent in our son’s chest since he was about 6 years old. Our pediatrician diagnosed this as pectus excavatum but ...